ALT
Asset Logo

Altimmune Inc

🇺🇸 NYSE/NASDAQ

Compare
Add to watchlist
👑 Overview

📈 Performance

💵 Cost

🍃 Esg

🤓 Advanced

👨‍👩‍👧‍👦 Community

📈

+ 85.85%
Annual Growth

5 years average annual growth

🌏

2
Pearlers Invested

Since January 2020

👑 Overview

Key information
🔎 Fund Overview

Altimmune, Inc. is a clinical-stage biopharmaceutical company focused on developing treatments for obesity and liver diseases. The Company's lead product candidate, pemvidutide, is a GLP-1/glucagon dual receptor agonist that is being developed for the treatment of obesity and metabolic dysfunction-associated steatohepatitis (MASH). The Company has completed the MOMENTUM Phase II obesity trial and is being studied in the IMPACT Phase IIb MASH trial. It is also developing HepTcell, an immunotherapeutic product candidate for patients chronically infected with the hepatitis B virus (HBV). The Company has completed the enrollment in its Phase II clinical trial of HepTcell. Its product candidates are based on its proprietary platform technologies, such as EuPort-based Peptide Technology and Synthetic Peptide Technology-Densigen. The Company’s wholly owned subsidiaries include Altimmune, LLC, Altimmune UK, Limited, Spitfire Pharma, LLC and Altimmune AU Pty, Limited.

📈 Performance

Price History*

-84.31%

1M

1Y

10Y

Graph

Table

* US price history does not take into account stock splits

Unsure how much or often to invest?
🗓️ Investing frequency calculator

Determine the investment frequency needed to reach your goals

Try it out →
💵 Investing amount calculator

Determine the recurring investment needed to reach your goals

Try it out →
⏱️ Investing duration calculator

Determine how long you will need to invest to reach your goals

Try it out →

💵 Costs

💵

6.50 AUD*
Purchase Fee

*$5.50 with Pearler Prepay

💼

N/A
Management Fee

Included in unit price, not charged by Pearler

💸

Want to know the long term costs?
Calculate the historic long term costs to hold your investments
💸 Net fee calculator

🤓 Advanced information

Technical Info

💰 Price*

$8.68

*Price may be up to 24 hours old

👩‍👩‍👦 Community Insights

How our community is investing

🌏 Pearlers invested in ALT

2

📊 Total Capital Earnings

N/A

🔃 Average investment frequency

34 weeks

💵 Average investment amount

$325

Last time a customer invested in ALT

185 days
ALT investor breakdown
💵 Income of investors

More than 200k

150k - 200k

100k - 150k

50%

50k - 100k

50%

Less than 50k

👶 Age of investors

18 - 25

50%

26 - 34

35 - 90

50%
🙋 Legal gender of investors

Female

100%

Male

Pearlers who invest in ALT also invest in...

Global X Lithium & Battery Tech ETF

LIT

🙌 Performance (5Yr p.a)

15.83%

📊 Share price

$44.97 USD

📈 HIGH PRICE GROWTH

Find Out More

🙌 Performance (5Yr p.a)

50.71%

📊 Share price

$138.35 USD

📈 HIGH PRICE GROWTH

🙌 Performance (5Yr p.a)

883.00%

📊 Share price

$197.12 USD

🙌 Performance (5Yr p.a)

18.32%

📊 Share price

$598.46 USD

📈 HIGH PRICE GROWTH

🙌 Performance (5Yr p.a)

518.51%

📊 Share price

$141.95 USD

📈 HIGH PRICE GROWTH

Want more shares? Try these...

🙌 Performance (5Yr p.a)

-3.99%

📊 Share price

$7.91 USD

🙌 Performance (5Yr p.a)

30.60%

📊 Share price

$119.65 USD

📈 HIGH PRICE GROWTH

Compare
Add to watchlist